{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:13:02Z","timestamp":1770433982132,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1053\/j.seminhematol.2008.02.005","type":"journal-article","created":{"date-parts":[[2008,3,29]],"date-time":"2008-03-29T11:11:02Z","timestamp":1206789062000},"page":"71-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Monoclonal Antibodies in Lymphoma: The First Decade"],"prefix":"10.1053","volume":"45","author":[{"given":"Brian K.","family":"Link","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan W.","family":"Friedberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2008.02.005_bib1","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1200\/JCO.2005.04.503","article-title":"Improved survival of follicular lymphoma patients in the United States","volume":"23","author":"Swenson","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib2","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1200\/JCO.2005.03.1674","article-title":"New treatment options have changed the survival of patients with follicular lymphoma","volume":"23","author":"Fisher","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib3","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1200\/JCO.2005.03.3696","article-title":"Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center","volume":"24","author":"Liu","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib4","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/cncr.22649","article-title":"Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients","volume":"109","author":"Sacchi","year":"2007","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib5","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"Hiddemann","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib6","doi-asserted-by":"crossref","first-page":"146a","DOI":"10.1182\/blood.V108.11.481.481","article-title":"MabThera (rituximab) plus cyclophosphamide, vincristine and prednisone (CVP) chemotherapy improves survival in previously untreated patients with advanced follicular non-Hodgkin\u2019s lymphoma (NHL)","volume":"108","author":"Marcus","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/blood.V104.11.160.160","article-title":"Rituximab added to \u03b1IFN+CHVP improves the outcome of follicular lymphoma patients with a high tumor burden: First analysis of the GELA-GOELAMS FL-2000 randomized trial in 359 patients","volume":"104","author":"Salles","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib8","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1200\/JCO.2006.06.4618","article-title":"Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: An East German Study Group Hematology and Oncology Study","volume":"25","author":"Herold","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib9","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2004-04-1323","volume":"104","author":"Forstpointner","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib10","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/jnci\/djk152","article-title":"Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: A systematic review and meta-analysis","volume":"99","author":"Schulz","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib11","first-page":"223a","article-title":"Rituximab plus CHOP is superior to CHOP alone in elderly patients with DLBCL","volume":"96","author":"Coiffier","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib13","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1200\/JCO.2005.09.137","article-title":"Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia","volume":"23","author":"Sehn","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib14","doi-asserted-by":"crossref","first-page":"1391a","DOI":"10.1182\/blood.V104.11.1391.1391","volume":"104","author":"Friedberg","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib15","doi-asserted-by":"crossref","first-page":"7527a","DOI":"10.1200\/jco.2006.24.18_suppl.7527","article-title":"Initial therapeutic strategy in follicular lymphoma: An analysis from the National LymphoCare study","volume":"24","author":"Friedberg","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib16","first-page":"393","article-title":"Effect of off-label use of oncology drugs on pharmaceutical costs: The rituximab experience","volume":"9","author":"Kocs","year":"2003","journal-title":"Am J Manag Care"},{"key":"10.1053\/j.seminhematol.2008.02.005_bib17","first-page":"782","article-title":"Will radioimmunotherapy survive?","volume":"5","author":"Zelenetz","year":"2007","journal-title":"Clin Adv Hematol Oncol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196308000061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196308000061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:18:52Z","timestamp":1758521932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196308000061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0037196308000061"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2008.02.005","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal Antibodies in Lymphoma: The First Decade","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2008.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}